Literature DB >> 7308333

Pulmonary reactions to nitrofurantoin. 447 cases reported to the Swedish Adverse Drug Reaction Committee 1966-1976.

L Holmberg, G Boman.   

Abstract

A dramatic increase in the number of adverse reactions to nitrofurantoin initiated a survey of the reports to the Swedish Adverse Drug Reaction Committee 1966-1976. Pulmonary reactions constituted about half of these reports: 398 cases with acute and 49 with chronic reactions. Three-quarters of the patients were hospitalized in connection with the reaction. Six reactions were fatal. The clinical picture and the laboratory findings differed considerably between the acute and chronic forms, although the age and sex distribution was very similar. About 85% of the patients were women. The median age was 59 years in the acute and 68 years in the chronic group. The acute pulmonary reactions carry the characteristics of an allergic reaction but we suggest that the chronic pulmonary and liver reactions may be caused by a toxic mechanism. Chronic reactions do not follow upon acute reactions, nor do acute reactions predispose to chronic ones. Early recognition of the reactions and prompt withdrawal of the drug are essential in both forms.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7308333

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  15 in total

1.  Nitrofurantoin-associated lung and liver toxicity leading to liver transplantation in a middle-aged patient.

Authors:  Tony K L Kiang; Jo-Ann Ford; Eric M Yoshida; Nilufar Partovi
Journal:  Can J Hosp Pharm       Date:  2011-07

2.  Chest pain, dyspnea, and cough.

Authors:  Val E Ginzburg
Journal:  Can Fam Physician       Date:  2006-09       Impact factor: 3.275

3.  Acute respiratory failure during pregnancy: a case of nitrofurantoin-induced pneumonitis.

Authors:  Aneez Mohamed; George K Dresser; Sanjay Mehta
Journal:  CMAJ       Date:  2007-01-30       Impact factor: 8.262

4.  Nitrofurantoin-induced interstitial pneumonitis: albeit rare, should not be missed.

Authors:  Haamid Syed; Ghassan Bachuwa; Sunil Upadhaya; Firas Abed
Journal:  BMJ Case Rep       Date:  2016-02-24

Review 5.  Drug-induced respiratory disorders: incidence, prevention and management.

Authors:  L Ben-Noun
Journal:  Drug Saf       Date:  2000-08       Impact factor: 5.606

6.  [Spectrum of hypereosinophilia syndrome based on 2 clinical case reports].

Authors:  H Nolte; U Helmchen
Journal:  Med Klin (Munich)       Date:  1998-07-15

7.  Recurrent nitrofurantoin-induced giant cell interstitial pneumonia: Case report and literature review.

Authors:  Boeun Lee; Arvind Balavenkataraman; Devang Sanghavi; Kristin Walter
Journal:  Respir Med Case Rep       Date:  2015-01-29

8.  Acute pulmonary function decline and radiographic abnormalities: chronic cause?

Authors:  Kathleen M Capaccione; Clement V Tran; Jay S Leb; Mary M Salvatore; Belinda D'souza
Journal:  Breathe (Sheff)       Date:  2021-03

9.  Acute respiratory distress syndrome and hepatotoxicity associated with single dose nitrofurantoin use.

Authors:  Gokhan Sargın; Osman Elbek; Cem Balantekin; Ibrahim Meteoglu; Nil Culhacı
Journal:  Case Rep Pulmonol       Date:  2012-11-27

10.  Reversible interstitial lung disease with prolonged use of nitrofurantoin: Do the benefits outweigh the risks?

Authors:  Akashdeep Singh; Parminder Singh; U S Sidhu
Journal:  Lung India       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.